Neboglamine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNeboglamine
Drug Alias Nameneboglamina奈波胺neboglaminumNebostinelXY-2401 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor agonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRottapharm
China Registration ClassN/A

Develop Information

Active CompaniesXytisRottapharm
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia